Cathie's Ark LogoCathie's Ark
BEGIN TYPING TO SEARCH BY TICKER
Trading Floor Community IconFrom the Trading Floor:
Editas Medicine Inc Logo

ARKG Holdings of Editas Medicine (EDIT) - Updated Daily

Lock Icon
Date
Direction
Shares
Fund Weight
Fund
October 11, 2021SELL100.357k0.054%ARKG
August 17, 2021BUY29.000k0.0212%ARKG
August 3, 2021BUY35.000k0.0168%ARKG
August 2, 2021BUY30.356k0.0147%ARKG
December 22, 2020SELL168.760k0.1914%ARKG
  • 1
  • 2
  • 5 / page

Key Statistics

Upcoming EarningsSee Full Calendar
DateFebruary 23, 2022(Est)Revenue
Expected$4.28m
Actual▫️
EPS
Expected-$0.72
Actual▫️
🕵🏼Found In🏷Last Price
ARKGARKK$18.69
⚖️Weighting🧢Market Cap
0.47%$1.28b
🏋🏿‍♂️Weight Rank In ARKG🧮Price to Sales
4552.19
🏋️‍♀️Weight Rank Across All Funds🌏Country
115🇺🇸United States
💳ARK Estimated Cost Average🎫ARK Ownership Percent
$29.861.48%
Description
As a leading genome editing company, Editas Medicine is focused on translating the power and potential of the CRISPR/Cas9 and CRISPR/Cas12a (also known as Cpf1) genome editing systems into a robust pipeline of treatments for people living with serious diseases around the world. Editas Medicine aims to discover, develop, manufacture, and commercialize transformative, durable, precision genomic medicines for a broad class of diseases. For the latest information and scientific presentations, please visit www.editasmedicine.com.
Website
www.editasmedicine.com

Research Notes and Commentary for EDIT